Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03784326
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:31.600108+00:00
Published At
2026-02-03T00:00:00+00:00
Record Updated At
2026-02-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Clinical Stage II Esophageal Adenocarcinoma AJCC v8", "Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8", "Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8", "Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8", "Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8", "Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8", "Clinical Stage III Esophageal Adenocarcinoma AJCC v8", "Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8", "Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8", "Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8", "Pathologic Stage II Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8", "Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8", "Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8", "Pathologic Stage III Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8", "Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8", "Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-03"
protocolSection.identificationModule.nctId
"NCT03784326"
protocolSection.identificationModule.officialTitle
"Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.